Sintilimab: Clinical Trials

2 trials for Sintilimab, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 unknown. 2 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable2Completed 1, Unknown 1

Follow Sintilimab: new trials by email Literature Review of Sintilimab trials Research Report on Sintilimab

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
bTAE-HAIC Combined With Lenvatinib and Sintilimab for Infiltrative Hepatocellular Carcinoma
bTAE-HAIC, Lenvatinib, Sintilimab - Liver Diseases, Hepatocellular Carcinoma
Not applicableUnknownSun Yat-sen University302024-05-202024-08-09
HAIC Combined With Lenvatinib and Sintilimab for Hepatocellular Carcinoma With PVTT
Hepatic arterial infusion chemotherapy, Lenvatinib, Sintilimab - Carcinoma, Hepatocellular, Liver Neoplasms
Not applicableCompletedSun Yat-sen University302021-01-012024-03-06

Narrower conditions

Carcinoma, Hepatocellular (2)  ·  Liver Diseases (1)  ·  Liver Neoplasms (1)

Broader conditions

Adenocarcinoma (2)  ·  Carcinoma (2)  ·  Digestive System Diseases (2)  ·  Digestive System Neoplasms (2)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Neoplasms by Site (2)  ·  Neoplasms, Glandular and Epithelial (2)  ·  Liver Diseases (1)  ·  Liver Neoplasms (1)

Interventions

Antibodies (2)  ·  lenvatinib (2)  ·  sintilimab (2)

Sponsors

Sun Yat-sen University (2)

Countries

China (2)

Top investigators

Jinhua Huang, Professor (1)  ·  Kangshun Zhu, MD (1)  ·  Zhimei Hunag, MD (1)